ATX vs EYE

ASX Healthcare sector comparison — updated 26 Mar 2026 — Healthcare sector

ATX

AMPLIA FPO [ATX]

59MEDIUM

EYE

NOVA EYE FPO [EYE]

55MEDIUM

Score Breakdown

ATX EYE
Technical
86
38
Catalyst
39
50
Sentiment
50
50
Fundamental
64
63
Momentum
82
60
Risk Gate
47
45

Key Metrics

ATX Metric EYE
$107.7MMarket Cap$37.0M
5.7MAvg Volume (20d)335K
+0.0%Short InterestN/A
$0.42552-Week High$0.205
$0.04952-Week Low$0.086
+0.8%Daily Change-3.8%
$0.262Entry Price$0.125
-28.5%ROE-42.4%
-158.5%Profit Margin-21.3%

Active Signals

ATX Signals

RSI is running hot — overbought territory, so expect some pullback risk
MACD momentum is picking up steam
Stochastic is stretched into overbought — could need a breather
Pressing against the upper Bollinger Band — extended and may need to cool off
Trading above both moving averages — the trend is your friend here
Volume surging at 55.0x normal while price climbs — real buying conviction behind this move
RSI is overbought but volume confirms it — this could be genuine momentum, not just froth
Just broke above 20-day resistance — a level that was capping price, now cleared

EYE Signals

RSI drifting toward oversold territory — worth watching
Trading below both moving averages — the trend is working against this one
Drifting lower — down 3.8% over the last 5 days
Below the 200-day average — the long-term trend is still working against it
Low cash runway (2 quarters) - dilution risk
Low P/S ratio (1.1x)
Strong revenue growth (+29%)
EPS estimates revised upward (+10pts)

Ask Scout AI to compare ATX and EYE in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
ATX Full Analysis → EYE Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).